Hemofiltration in human sepsis: Evidence for elimination of immunomodulatory substances

Kidney International

Volumn 48, Issue 5, 1995, Pages 1563-1570

  Hoffmann, Johannes N ^b   Hartl, Wolfgang H ^b   Deppisch, Reinhold ^b   Faist, Eugen ^b   Jochum, Marianne ^b   Inthorn, Dietrich ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT; CYTOKINE; IMMUNOMODULATING AGENT; TUMOR NECROSIS FACTOR ALPHA;

ACUTE KIDNEY FAILURE; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEMOFILTRATION; HUMAN; LEUKOCYTE; MALE; PRIORITY JOURNAL; SEPSIS;

EID: 0028885681     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1995.448     Document Type: Article

References (41)

1. PERTOSA G, TARANTINO EA, GESUALDO L, MONTINARO V, SCHENA FP: C5b-9 generation and cytokine production in hemodialyzed patients. Kidney Int 43(Suppl 41):S221-S225, 1993
2. BARTLETT RH, MAULT JR, DECHERT RE, PALMER J, SWARTZ RD, PORT FK: Continuous arteriovenous hemofiltration: Improved survival in surgical acute renal failure? Surgery 100:400-408, 1986
3. RONCO C: Continuous renal replacement therapies for the treatment of acute renal failure in intensive care patients. Clin Nephrol 40:187-198, 1993
4. STORCK M, HARTL WH, ZIMMERER E, INTHORN D: Comparison of pump-driven and spontaneous continuous haemofiltration in postoperative acute renal failure. Lancet 337:452-455, 1991
5. GOMEZ A, WANG R, UNRUH H, LIGHT RB, BOSE D, CHAU T, CORREA E, MINK S: Hemofiltration reverses left ventricular dysfunction during sepsis in dogs. Anesthesiology 73:671-685, 1990
6. GROOTENDORST AF, VAN BOMMEL EFH, VAN DER HOVEN B, VAN LEENGOED LA, VAN OSTA ALM: High volume hemofiltration improves right ventricular function in endotoxin-induced shock in the pig. Intensive Care Med 18:235-240, 1992
7. STEIN B, PFENNINGER E, GRÜNERT A, SCHMITZ JE, HUDDE M: Influence of continuous haemofiltration on haemodynamics and central blood volume in experimental endotoxic shock. Intensive Care Med 16:494-499, 1990
8. STEIN B, PFENNINGER E, GRÜNERT A, SCHMITZ JE, DELLER A, KOCHER F: The consequences of continuous hemofiltration on lung mechanics and extravascular lung water in a porcine endotoxin shock model. Intensive Care Med 17:293-298, 1991
9. HEIDEMANN S, OFENSTEIN J, SARNAIK A: Efficacy of continuous arterio-venous hemofiltration (CAVH) in endotoxic shock. (abstract) Crit Care Med 21(Suppl):S159, 1993
10. LEE PA, MATSON JR, PRYOR RW, HINSHAW LB: Continuous arteriovenous hemofiltration therapy for Staphylococcus aureus-induced septicemia in immature swine. Crit Care Med 21:914-924, 1993
11. BELLOMO R, TIPPING P, BOYCE N: Continuous veno-venous hemofiltration with dialysis removes cytokines from the circulation of septic patients. Crit Care Med 21:522-526, 1993
12. BONE RC: The pathogenesis of sepsis. Ann Int Med 115:457-469, 1991
13. GARDINALI M, PADALINO P, VESCONI S, CALCAGNO A, CIAPPELLANO S, CONCIATO L, CHIARA O, AGOSTONI A, NESPOLI A: Complement activation and polymorphonuclear neutrophil leukocyte elastase in sepsis. Arch Surg 127:1219-1224, 1992
14. BONE RC, BALK RA, CERRA FB, DELLINGER RP, FEIN AM, KNAUS WA, SCHEIN RM, SIBBALD WJ: The ACCP/SCCM Consensus Conference Committee: Definitions for sepsis and organ failure and guidlines for the use of innovative therapies in sepsis. Crit Care Med 20:864-874, 1992
15. ELEBUTE EA, STONER HB: The grading of sepsis. Br J Surg 70:29-31, 1983
16. VAN SNICK J, CAYPHAS S, VINK A: Purification and NH2-terminal amino acid sequence of a T-cell derived lymphokine with growth factor activity for B-cell hybridomas. Proc Natl Acad Sci USA 83:9679-9683, 1989
17. ESPEVIK T, NISSEN-MEYER J: A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J Immunol Meth 95:99-105, 1986
18. ESKANDARI MK, NGUYEN DT, KUNKEL SL, REMICK DG: WEHI subclone 13 assay for TNF: Sensitivity, specificity and reliability. Immunol Invest 19:69-79, 1990
19. GILLIS S, FERM MM, OU W, SMITH KA: T-cell growth factors: Parameters of production and a quantitative micro-assay for activity. J Immunol 120:2027-2032, 1978
20. DEPPISCH R, SCHMITT V, BOMMER J, HÄNSCH GM, RITZ E, RAUTERBERG EW: Fluid phase generation of terminal complement complex as a novel index of bioincompatibility. Kidney Int 37:696-706, 1990
21. FAIST E, MEWES A, BAKER CC, STRASSER T, ALKAN SS, RIEBER P, HEBERER G: Prostaglandin E2 (PGE2)-dependent suppression of interleukin-2 (IL-2) production in patients with minor trauma. J Trauma 27:837-848, 1987
22. MUNOZ C, CARLET J, FITTING C, MISSET B, BLERIOT JP, CAVAILLON JM: Dysregulation of in vitro cytokine production by monocytes during sepsis. J Clin Invest 88:1747-1754, 1991
23. HAKIM RM, BREILLAT TJ, LAZARUS JM, PORT FK: Complement activation and hypersensitivity reactions to dialysis membranes. N Engl J Med 311:878-882, 1984
24. GÖHL H, BUCK R, STRATHMANN R: Basic features of the polyamide membranes. Contrib Nephrol 96:1-25, 1991
25. LOWRY SF: Cytokine mediators of immunity and inflammation. Arch Surg 128:1235-1241, 1993
26. LAMARRE J, WOLLENBERG GK, GONIAS SL, HAYES MA: Biology of disease: Cytokine binding and clearance properties of proteinase-activated alpha 2-macroglobulin. Lab Invest 65:3-14, 1991
27. LONNEMANN G, SCHINDLER R, DINARELLO CA, KOCH KM: Removal of circulating cytokines by hemodialysis membranes in vitro, in Host Defense Dysfunction in Trauma, Shock and Sepsis, edited by FAIST E, MEAKINS JE, SCHILDBERG FW, Berlin, Heidelberg, New York, Springer Verlag, 1994, pp 613-623
28. TONNESEN E, HANSEN MB, HÖHNDORF K, DIAMANT M, BENDTZEN K, WANSCHER M, TOFT P: Cytokines in plasma and ultrafiltrate during continuous arteriovenous hemofiltration. Anaesth Intens Care 21:752-758, 1993
29. GOLDFARB S, GOLPER T: Proinflammatory cytokines and hemofiltration membranes. JASN 5:228-232, 1994
30. KLAPPROTH J, CASTELL J, GEIGER J, ANDUS T, HEINRICH PC: Fate and biological action of human recombinant interleukin 1 beta in the rat in vivo. Eur J Immunol 19:1485-1490, 1989
31. ANDREASSON S, GOETHBERG S, BERGGREN H, BENGTSSON A, ERIKSSON E, RISBERG B: Hemofiltration modifies complement activation after extracorporeal circulation in infants. Ann Thorac Surg 56:1515-1517, 1993
32. HOFFMANN JN, HARTL WH, DEPPISCH R, FAIST E, JOCHUM M, INTHORN D: Effect of high-volume hemofiltration on hemodynamics and systemic concentrations of anaphylatoxins and cytokines in human sepsis. (submitted for publication)
33. DOFFERHOFF AS, DE JONG HJ, BOM VJ, VAN DER MEER J, LIMBURG PC, DE VRIES HOSPERS HG, MARRINK J, MULDER PO, WEITS J: Complement activation and the production of inflammatory mediators during the treatment of severe sepsis in humans. Scand J Infect Dis 24:197-204, 1992
34. SCHINDLER R, DINARELLO CA: A method for removing interleukin-1-and tumor necrosis factor-inducing substances from bacterial cultures by ultrafiltration with polysulfone. J Immunol Meth 116:159-165, 1989
35. desArg) induces production and release of interleukin 1 by cultured human monocytes. J Immunol 139:794-799, 1987
36. 2 of TNF alpha and IL-1 β production by human monocytes. Immunology 66:376-383, 1989
37. WAAGE A, BRANDTZAEG P, HALSTENSEN A, KIERULF P, ESPERIK T: The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome. J Exp Med 169:333-338, 1989
38. WOOD JJ, RODRICK ML, O'MAHONEY JB, PALDER SP, SAPOROSCHETZ I, D'EON P, MANNICK JA: Inadequate interleukin 2 production: A fundamental immunological deficiency in patients with major burns. Ann Surg 200:311-320, 1984
39. FAIST E, KUPPER TS, BAKER CC, CHAUDRY IH, DWYER J, BAUE AE: Depression of cellular immunity after major injury. Arch Surg 121: 1000-1013, 1986
40. SCHIFFL H, LANG SM, KÖNIG A, STRASSER T, HAIDER MC, HELD E: Biocompatible membranes in acute renal failure: Prospective case-controlled study. Lancet 344:570-572, 1994
41. HÖRL WH, HAAG-WEBER M, GEORGOPOULOS A, BLOCK LH: Physicochemical characterization of a polypeptide present in uremic serum that inhibits the biological activity of polymorphonuclear cells. Proc Natl Acad Sci USA 87:6353-6357, 1990